A detailed history of Farther Finance Advisors, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 50 shares of CDXS stock, worth $256. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 38 31.58%
Holding current value
$256
Previous $114,000 35.09%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$2.62 - $3.71 $31 - $44
12 Added 31.58%
50 $154,000
Q2 2024

Jul 31, 2024

SELL
$2.65 - $3.92 $60 - $90
-23 Reduced 37.7%
38 $114,000
Q1 2024

May 13, 2024

SELL
$2.59 - $4.65 $132 - $237
-51 Reduced 45.54%
61 $213,000
Q4 2023

Feb 14, 2024

BUY
$1.54 - $3.37 $172 - $377
112 New
112 $342,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.